Steven Cohen Bio Rad Laboratories, Inc. Transaction History

Point72 Asset Management, L.P.

$36.6 Billion
Q3 2024

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 250,108 shares of BIO stock, worth $85.4 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

250,108

Holding current value

$85.4 Million

% of portfolio

0.23%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$263.97 - $344.64 $66 Million - $86.2 Million	250,108 New	250,108 $83.7 Million
Q1 2024 May 15, 2024	BUY	$304.11 - $351.99 $21.7 Million - $25.1 Million	71,400 New	71,400 $24.7 Million
Q2 2023 Aug 14, 2023	SELL	$359.49 - $486.4 $36.4 Million - $49.3 Million	-101,391 Reduced 57.99%	73,459 $27.8 Million
Q1 2023 May 15, 2023	BUY	$418.69 - $503.0 $21.1 Million - $25.4 Million	50,424 Added 40.53%	174,850 $83.8 Million
Q4 2022 Feb 14, 2023	BUY	$351.71 - $456.01 $12.3 Million - $15.9 Million	34,908 Added 39.0%	124,426 $52.3 Million
Q3 2022 Nov 14, 2022	SELL	$412.59 - $563.26 $21.5 Million - $29.4 Million	-52,164 Reduced 36.82%	89,518 $37.3 Million
Q2 2022 Aug 15, 2022	BUY	$463.67 - $597.16 $12.2 Million - $15.7 Million	26,279 Added 22.77%	141,682 $70.1 Million
Q1 2022 May 16, 2022	BUY	$524.57 - $735.42 $19.1 Million - $26.7 Million	36,345 Added 45.97%	115,403 $65 Million
Q4 2021 Feb 14, 2022	BUY	$708.84 - $794.68 $30.9 Million - $34.6 Million	43,534 Added 122.55%	79,058 $59.7 Million
Q3 2021 Nov 15, 2021	BUY	$657.71 - $825.77 $15.6 Million - $19.6 Million	23,724 Added 201.05%	35,524 $26.5 Million
Q2 2021 Aug 16, 2021	BUY	$576.64 - $649.04 $6.8 Million - $7.66 Million	11,800 New	11,800 $7.6 Million
Q1 2021 May 17, 2021	SELL	$547.01 - $662.35 $3.45 Million - $4.17 Million	-6,300 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$510.68 - $643.45 $3.22 Million - $4.05 Million	6,300 New	6,300 $3.67 Million
Q3 2020 Nov 16, 2020	SELL	$454.43 - $535.6 $6.5 Million - $7.66 Million	-14,305 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$334.87 - $493.06 $4.79 Million - $7.05 Million	14,305 New	14,305 $6.46 Million
Q1 2020 May 15, 2020	SELL	$320.01 - $409.07 $11.1 Million - $14.3 Million	-34,842 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$319.73 - $374.2 $33.1 Million - $38.7 Million	-103,441 Reduced 74.8%	34,842 $12.9 Million
Q3 2019 Nov 15, 2019	SELL	$304.55 - $345.24 $44.7 Million - $50.7 Million	-146,736 Reduced 51.48%	138,283 $46 Million
Q2 2019 Aug 14, 2019	BUY	$286.93 - $312.59 $42.4 Million - $46.2 Million	147,643 Added 107.47%	285,019 $89.1 Million
Q1 2019 May 15, 2019	BUY	$224.3 - $317.41 $2.45 Million - $3.46 Million	10,901 Added 8.62%	137,376 $42 Million
Q4 2018 Feb 14, 2019	SELL	$220.1 - $309.0 $896,027 - $1.26 Million	-4,071 Reduced 3.12%	126,475 $29.4 Million
Q3 2018 Nov 14, 2018	BUY	$289.28 - $326.15 $8.95 Million - $10.1 Million	30,943 Added 31.07%	130,546 $40.9 Million
Q2 2018 Aug 14, 2018	SELL	$244.1 - $303.88 $2.1 Million - $2.61 Million	-8,597 Reduced 7.95%	99,603 $28.7 Million
Q1 2018 May 15, 2018	BUY	$233.97 - $274.11 $25.3 Million - $29.7 Million	108,200 New	108,200 $27.1 Million

Others Institutions Holding BIO

# of Institutions

457

Shares Held

18.2M

Call Options Held

19.5K

Put Options Held

13.9K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.41B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account